Steven Cohen Celldex Therapeutics, Inc. Transaction History

Point72 Asset Management, L.P.

$51 Billion
Q3 2025

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 3,893,942 shares of CLDX stock, worth $99.5 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

3,893,942

Previous 2,801,721 38.98%

Holding current value

$99.5 Million

Previous $57 Million 76.68%

% of portfolio

0.2%

Previous 0.13%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$20.01 - $26.19 $21.9 Million - $28.6 Million	1,092,221 Added 38.98%	3,893,942 $101 Million
Q2 2025 Aug 14, 2025	BUY	$15.13 - $21.65 $2.73 Million - $3.91 Million	180,546 Added 6.89%	2,801,721 $57 Million
Q1 2025 May 15, 2025	BUY	$18.15 - $27.6 $1.91 Million - $2.9 Million	105,203 Added 4.18%	2,621,175 $47.6 Million
Q4 2024 Feb 14, 2025	BUY	$23.31 - $32.4 $22.1 Million - $30.7 Million	947,264 Added 60.38%	2,515,972 $63.6 Million
Q3 2024 Nov 14, 2024	SELL	$32.06 - $44.56 $11.8 Million - $16.5 Million	-369,283 Reduced 19.05%	1,568,708 $53.3 Million
Q2 2024 Aug 14, 2024	BUY	$32.76 - $42.56 $21.4 Million - $27.8 Million	654,194 Added 50.96%	1,937,991 $71.7 Million
Q1 2024 May 15, 2024	SELL	$35.22 - $51.88 $51.9 Million - $76.4 Million	-1,472,325 Reduced 53.42%	1,283,797 $53.9 Million
Q4 2023 Feb 14, 2024	BUY	$22.61 - $40.65 $32 Million - $57.5 Million	1,413,722 Added 105.31%	2,756,122 $109 Million
Q3 2023 Nov 14, 2023	BUY	$25.45 - $37.46 $4.01 Million - $5.9 Million	157,600 Added 13.3%	1,342,400 $36.9 Million
Q2 2023 Aug 14, 2023	BUY	$30.29 - $38.28 $28.9 Million - $36.6 Million	955,297 Added 416.25%	1,184,800 $40.2 Million
Q1 2023 May 15, 2023	SELL	$34.78 - $47.43 $9.61 Million - $13.1 Million	-276,297 Reduced 54.63%	229,503 $8.26 Million
Q4 2022 Feb 14, 2023	BUY	$27.78 - $45.38 $10.3 Million - $16.8 Million	370,800 Added 274.67%	505,800 $22.5 Million
Q3 2022 Nov 14, 2022	BUY	$22.7 - $37.57 $3.06 Million - $5.07 Million	135,000 New	135,000 $3.8 Million
Q2 2021 Aug 16, 2021	SELL	$20.71 - $35.37 $954,731 - $1.63 Million	-46,100 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$16.19 - $29.91 $746,359 - $1.38 Million	46,100 New	46,100 $950,000

Others Institutions Holding CLDX

# of Institutions

204

Shares Held

68.2M

Call Options Held

227K

Put Options Held

225K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.2B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account